Annual CFF
$348.00 K
+$348.00 K+100.00%
December 31, 2023
Summary
- As of February 8, 2025, EKSO annual cash flow from financing activities is $348.00 thousand, with the most recent change of +$348.00 thousand (+100.00%) on December 31, 2023.
- During the last 3 years, EKSO annual CFF has fallen by -$10.36 million (-96.75%).
- EKSO annual CFF is now -99.18% below its all-time high of $42.57 million, reached on December 31, 2017.
Performance
EKSO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$4.69 M
+$4.96 M+1870.19%
September 30, 2024
Summary
- As of February 8, 2025, EKSO quarterly cash flow from financing activities is $4.69 million, with the most recent change of +$4.96 million (+1870.19%) on September 30, 2024.
- Over the past year, EKSO quarterly CFF has increased by +$4.96 million (+1870.19%).
- EKSO quarterly CFF is now -87.88% below its all-time high of $38.71 million, reached on March 31, 2021.
Performance
EKSO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$8.43 M
+$4.69 M+125.43%
September 30, 2024
Summary
- As of February 8, 2025, EKSO TTM cash flow from financing activities is $8.43 million, with the most recent change of +$4.69 million (+125.43%) on September 30, 2024.
- Over the past year, EKSO TTM CFF has increased by +$4.69 million (+125.43%).
- EKSO TTM CFF is now -83.54% below its all-time high of $51.23 million, reached on September 30, 2017.
Performance
EKSO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
EKSO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | +1870.2% | +125.4% |
| 3 y3 years | -96.8% | +100.0% | -78.2% |
| 5 y5 years | -84.7% | +884.5% | -55.7% |
EKSO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.1% | -100.0% | at high | +1870.2% | -78.2% | -100.0% |
| 5 y | 5-year | -99.1% | -100.0% | -87.9% | +896.4% | -83.1% | -100.0% |
| alltime | all time | -99.2% | -100.0% | -87.9% | +884.5% | -83.5% | -100.0% |
Ekso Bionics Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.69 M(-1870.2%) | $8.43 M(+125.4%) |
| Jun 2024 | - | -$265.00 K(-107.2%) | $3.74 M(-6.6%) |
| Mar 2024 | - | $3.66 M(+950.9%) | $4.00 M(+1050.9%) |
| Dec 2023 | $348.00 K(>+9900.0%) | $348.00 K(>+9900.0%) | $348.00 K(>+9900.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | $0.00(-100.0%) | - | - |
| Dec 2021 | $38.71 M(+261.7%) | $0.00(0.0%) | $38.71 M(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $38.71 M(-6.2%) |
| Jun 2021 | - | $0.00(-100.0%) | $41.26 M(-17.5%) |
| Mar 2021 | - | $38.71 M(>+9900.0%) | $50.01 M(+367.2%) |
| Dec 2020 | $10.70 M(-43.8%) | $0.00(-100.0%) | $10.70 M(-28.5%) |
| Sep 2020 | - | $2.54 M(-70.9%) | $14.97 M(+26.6%) |
| Jun 2020 | - | $8.75 M(-1585.4%) | $11.83 M(+1.3%) |
| Mar 2020 | - | -$589.00 K(-113.8%) | $11.68 M(-38.6%) |
| Dec 2019 | $19.04 M(+737.6%) | $4.27 M(-813.9%) | $19.04 M(+29.8%) |
| Sep 2019 | - | -$598.00 K(-107.0%) | $14.67 M(-21.3%) |
| Jun 2019 | - | $8.60 M(+27.0%) | $18.64 M(+97.4%) |
| Mar 2019 | - | $6.77 M(-6608.7%) | $9.44 M(+315.4%) |
| Dec 2018 | $2.27 M(-94.7%) | -$104.00 K(-103.1%) | $2.27 M(-8.6%) |
| Sep 2018 | - | $3.37 M(-666.6%) | $2.49 M(-91.9%) |
| Jun 2018 | - | -$595.00 K(+49.1%) | $30.65 M(-27.3%) |
| Mar 2018 | - | -$399.00 K(-466.1%) | $42.17 M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $42.57 M(+82.6%) | $109.00 K(-99.7%) | $42.57 M(-16.9%) |
| Sep 2017 | - | $31.54 M(+188.8%) | $51.23 M(+48.9%) |
| Jun 2017 | - | $10.92 M(>+9900.0%) | $34.40 M(+46.6%) |
| Mar 2017 | - | $2000.00(-100.0%) | $23.47 M(+0.7%) |
| Dec 2016 | $23.31 M(+65.0%) | $8.77 M(-40.4%) | $23.31 M(-18.4%) |
| Sep 2016 | - | $14.71 M(<-9900.0%) | $28.57 M(+106.0%) |
| Jun 2016 | - | -$8000.00(-95.1%) | $13.87 M(-0.3%) |
| Mar 2016 | - | -$164.00 K(-101.2%) | $13.91 M(-1.5%) |
| Dec 2015 | $14.12 M(-65.4%) | $14.03 M(>+9900.0%) | $14.12 M(-34.3%) |
| Sep 2015 | - | $10.00 K(-66.7%) | $21.49 M(-0.1%) |
| Jun 2015 | - | $30.00 K(-42.3%) | $21.52 M(+0.3%) |
| Mar 2015 | - | $52.00 K(-99.8%) | $21.45 M(-47.5%) |
| Dec 2014 | $40.88 M(>+9900.0%) | $21.40 M(>+9900.0%) | $40.88 M(+109.8%) |
| Sep 2014 | - | $40.00 K(-203.4%) | $19.48 M(+0.2%) |
| Jun 2014 | - | -$38.70 K(-100.2%) | $19.44 M(-0.2%) |
| Mar 2014 | - | $19.48 M(>+9900.0%) | $19.48 M(>+9900.0%) |
| Dec 2013 | - | $1500.00(>+9900.0%) | $1000.00(-94.6%) |
| Sep 2013 | - | $0.00(0.0%) | $18.50 K(-32.2%) |
| Jun 2013 | - | $0.00(-100.0%) | $27.30 K(-16.5%) |
| Mar 2013 | - | -$500.00(-102.6%) | $32.70 K(-1.5%) |
| Mar 2013 | $32.70 K | - | - |
| Dec 2012 | - | $19.00 K(+115.9%) | $33.20 K(+133.8%) |
| Sep 2012 | - | $8800.00(+63.0%) | $14.20 K(+163.0%) |
| Jun 2012 | - | $5400.00 | $5400.00 |
FAQ
- What is Ekso Bionics Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Ekso Bionics Holdings?
- What is Ekso Bionics Holdings annual CFF year-on-year change?
- What is Ekso Bionics Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Ekso Bionics Holdings?
- What is Ekso Bionics Holdings quarterly CFF year-on-year change?
- What is Ekso Bionics Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Ekso Bionics Holdings?
- What is Ekso Bionics Holdings TTM CFF year-on-year change?
What is Ekso Bionics Holdings annual cash flow from financing activities?
The current annual CFF of EKSO is $348.00 K
What is the all time high annual CFF for Ekso Bionics Holdings?
Ekso Bionics Holdings all-time high annual cash flow from financing activities is $42.57 M
What is Ekso Bionics Holdings annual CFF year-on-year change?
Over the past year, EKSO annual cash flow from financing activities has changed by +$348.00 K (+100.00%)
What is Ekso Bionics Holdings quarterly cash flow from financing activities?
The current quarterly CFF of EKSO is $4.69 M
What is the all time high quarterly CFF for Ekso Bionics Holdings?
Ekso Bionics Holdings all-time high quarterly cash flow from financing activities is $38.71 M
What is Ekso Bionics Holdings quarterly CFF year-on-year change?
Over the past year, EKSO quarterly cash flow from financing activities has changed by +$4.96 M (+1870.19%)
What is Ekso Bionics Holdings TTM cash flow from financing activities?
The current TTM CFF of EKSO is $8.43 M
What is the all time high TTM CFF for Ekso Bionics Holdings?
Ekso Bionics Holdings all-time high TTM cash flow from financing activities is $51.23 M
What is Ekso Bionics Holdings TTM CFF year-on-year change?
Over the past year, EKSO TTM cash flow from financing activities has changed by +$4.69 M (+125.43%)